Mark Schlotterback, MD
Psychiatry · Los Angeles
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 21
- 3 carriers
- Office
- 1
- Since medical school
- 9 years
- Graduated 2017
Offices
1 location · Mellow Medical Inc A Professional Corporation · 30 clinicians in this group
Plans that list them
21 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Schlotterback’s office at (888) 684-2779 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
21 of 21 plans
California Medical Board record
Licence A172152 · Current
Licensed to practise in California · since 2021 · expires 2027-04-30 · University of North Dakota School of Medicine and Health Sciences.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Psychiatry and Neurology - Psychiatry
Drugs they prescribed that Part D paid
$1,315
Pharmacies billed $1,315 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 73) in 2024. At or below the middle of the specialty; the typical psychiatry & neurology clinician is at 0%.
73 generic and 0 brand-name prescriptions · $1,315 in drug cost · 12 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Bupropion Xl | 11 | $340 | $31 |
| Escitalopram | 15 | $105 | $7 |
Year by year
| 2024 | 73 | None | 0% (0) | 0% | $1,315 |
| 2023 | 28 | None | 0% (0) | 0% | $832 |
| 2022 | 16 | None | 0% (0) | 0% | $289 |
| 2021 | 325 | 37 | 0% (0) | 9% | $32,906 |
| 2020 | 862 | 79 | 0% (0) | 8% | $65,458 |
| 2019 | 303 | 56 | 0% (0) | 9% | $32,673 |
| 2018 | 279 | 57 | None | 10% | $15,925 |
| 2017 | 51 | 18 | 0% (0) | None | $1,350 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2021: 11 drugs
| Viibryd | 15 | $5,807 | $387 |
| Bupropion Xl | 15 | $2,203 | $147 |
| Buspirone | 13 | $715 | $55 |
| Quetiapine | 20 | $599 | $30 |
| Duloxetine | 21 | $475 | $23 |
| Lamotrigine | 20 | $310 | $15 |
| Trazodone | 27 | $302 | $11 |
| Paroxetine | 15 | $209 | $14 |
| Lorazepam | 15 | $154 | $10 |
| Fluoxetine | 11 | $148 | $13 |
| Clonazepam | 14 | $147 | $10 |
2020: 32 drugs
| Latuda | 14 | $19,172 | $1,369 |
| Viibryd | 40 | $13,832 | $346 |
| Aripiprazole | 29 | $4,266 | $147 |
| Divalproex | 46 | $2,689 | $58 |
| Bupropion Xl | 11 | $1,804 | $164 |
| Quetiapine | 66 | $1,783 | $27 |
| Divalproex Sodium Er | 19 | $1,105 | $58 |
| Risperidone | 41 | $918 | $22 |
| Duloxetine | 30 | $754 | $25 |
| Lamotrigine | 51 | $725 | $14 |
| Trazodone | 55 | $542 | $10 |
| Gabapentin | 27 | $541 | $20 |
| Haloperidol | 18 | $523 | $29 |
| Olanzapine | 20 | $519 | $26 |
| Bupropion Hcl Sr | 17 | $517 | $30 |
| Mirtazapine | 30 | $396 | $13 |
| Buspirone | 20 | $337 | $17 |
| Sertraline | 33 | $328 | $10 |
| Oxcarbazepine | 15 | $281 | $19 |
| Venlafaxine | 11 | $272 | $25 |
| Fluoxetine | 29 | $264 | $9 |
| Topiramate | 13 | $256 | $20 |
| Venlafaxine Hcl Er | 11 | $230 | $21 |
| Benztropine Mesylate | 21 | $191 | $9 |
| Lorazepam | 13 | $189 | $15 |
| Donepezil | 17 | $152 | $9 |
| Memantine | 14 | $146 | $10 |
| Alprazolam | 19 | $130 | $7 |
| Paroxetine | 11 | $130 | $12 |
| Citalopram Hbr | 28 | $128 | $5 |
| Clonazepam | 17 | $94 | $6 |
| Diazepam | 11 | $86 | $8 |
2019: 9 drugs
| Quetiapine | 31 | $741 | $24 |
| Duloxetine | 16 | $558 | $35 |
| Bupropion Xl | 12 | $391 | $33 |
| Clozapine | 14 | $322 | $23 |
| Trazodone | 22 | $284 | $13 |
| Haloperidol | 11 | $211 | $19 |
| Fluoxetine | 12 | $184 | $15 |
| Clonazepam | 12 | $59 | $5 |
| Citalopram Hbr | 25 | $59 | $2 |
2018: 8 drugs
| Duloxetine | 15 | $602 | $40 |
| Mirtazapine | 23 | $441 | $19 |
| Quetiapine | 20 | $272 | $14 |
| Lorazepam | 11 | $148 | $13 |
| Lamotrigine | 12 | $113 | $9 |
| Clonazepam | 11 | $97 | $9 |
| Diazepam | 11 | $81 | $7 |
| Citalopram Hbr | 12 | $48 | $4 |
Money from drug and device companies
$83 in 2025
| 2025 | 2 | 4 | None | $83 |
| 2023 | 1 | 1 | None | $15 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novo Nordisk | Ozempic | $53 | 3 payments
|
| Eisai | Leqembi | $30 | 1 payment
|
See all 4 published payments
| Eisai | Meals · 2025-12-01 | Leqembi | $30 |
| Novo Nordisk | Meals · 2025-10-17 | Ozempic | $17 |
| Novo Nordisk | Meals · 2025-09-19 | Ozempic | $19 |
| Novo Nordisk | Meals · 2025-05-19 | Ozempic | $17 |
See earlier years (2023)
2023: $15
| Lilly USA | Jardiance | $15 | 1 payment
|
Professional record
- NPI
- 1346775921
- Licence
- CA 172152California A172152: Current · expires 2027-04-30
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Psychiatry (2084P0800X); Student in a training program (390200000X)
- Mailing address
- 12301 Wilshire Blvd Ste 512, Los Angeles, CA, 90025
- NPI first listed
- 2017-04-20
- NPI last updated
- 2021-09-24
- NPI record certified
- 2021-09-24
This is when the NPI record was last certified, not a medical board exam.